<DOC>
	<DOC>NCT01097850</DOC>
	<brief_summary>The purpose of this study is to determine whether henna paste is effective in the treatment of hand-foot skin syndrome, induced by the drugs Capecitabine and pegylated liposomal doxorubicin.</brief_summary>
	<brief_title>Topical Henna Preparation for the Treatment of Hand Foot Skin Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Lawsone</mesh_term>
	<criteria>Patients receiving capecitabine and/or pegylated liposomal doxorubicin as monotherapy or in combination with other agents New diagnosis of active handfoot skin reaction (on bilateral hands and/or bilateral feet) of 13 toxicity as defined by the NCICTCAE version 4.0 grading scale with onset of symptoms within the last thirty days Patients must be 18 years or older Patients must provide written informed consent to participate in the study Patients with preexisting dermatological condition affecting the hands or feet that may limit the interpretation of results Known allergy to natural henna Patients with a previous history of HFS History of G6PD deficiency as determined by screening bloodwork</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>hand foot skin syndrome</keyword>
	<keyword>palmar plantar erythrodysesthesia</keyword>
	<keyword>doxorubicin</keyword>
	<keyword>capecitabine</keyword>
</DOC>